High Profile CEO Life Sciences Delegation From Austria Announce Their Visit to America in December 2012

Chief Executive Officers representing six flagship Medical Technology companies from Austria will visit Minneapolis and Boston during a one-week trip (December 3-8, 2012) to engage in a program designed to stimulate foreign trade and collaborations.

PRINCETON, NJ (I-Newswire) September 4, 2012 - Chief Executive Officers (CEOs) representing six flagship Medical Technology companies from Austria will visit Minneapolis and Boston during a one-week trip (December 3-8, 2012) to engage in a busy and substantive program designed to stimulate business and collaborations with US Medical Technology and other life science companies located in Minnesota and Massachusetts.

This program is supported by ADVANTAGE AUSTRIA, the Austrian Foreign Trade Promotion Organization is the largest provider of services in the area of foreign trade. The program is designed and operated by MedNest, a US-based enterprise and developer of innovative medical technology companies.

“Biotechnology, Medical Technology and Life Sciences are among the key technologies of the 21st century. In Austria, the existing networks of established Medical Technology companies, dynamic young biotechnology firms, leading research institutes and universities, as well as important clusters, provide the ideal springboard for a successful future. This program will generate growth prospect for the all the participating companies and reinforce the already strong relationship between the US and our Country”, says Christian Kesberg, Trade Commissioner of Austria in the US.

The program offered to the delegation includes several workshops to address key challenges of introducing Medical Technologies to the US markets, ranging from clinical and economic evaluation of these technologies to possible business models for foreign companies to create a footprint in the USA. Regulatory (FDA) discussion is regularly included in the program.

“This is the seventh and 2012 edition of this Transatlantic Economic Development program, and the compounded economic impact for the US ecosystems is poised to be significant in the coming 2-3 years” says Mathieu Petitjean, Ph.D., CEO of MedNest

During the program, CEOs will be exposed to multiple targeted business development and technology partnership opportunities with several US companies. All the companies will participate to the Annual Life Science Alley Conference & Expo (Dec 5th 2012, Minneapolis), a high profile MedTech industry event, with more than 200 organizations represented in the Exhibit Hall and a strong Conference Program.

The six companies from Austria are in the following technologies and markets:

- Innovative patient ventilation systems for intensive care units
- Minimally invasive dental surgery device for sinus bone augmentation
- Blood bag temperature monitoring technology
- Remote compliance monitoring for orthodontic appliances
- Eye and vision tracking systems
- Non-invasive magnetic induction therapy for equine wound care and other indications

Companies interested in connecting with the CEOs from this Austrian Delegation are invited to reach out to Advantage Austria or MedNest.

About Advantage Austria
The Austrian Trade Commissions in the United States (Österreichische AußenwirtschaftsCenter) are regional offices of the Austrian Federal Economic Chamber (Wirtschaftskammer Österreich, WKO). These offices offer Austrian and Austrian-funded businesses in the U.S. a wide array of information and individual consulting services. Advantage Austria promotes and protects Austria’s commercial interests in the US and deliver customized business support and consultancy services to Austrian companies and their US subsidiaries. Advantage Austria also assist US companies with trade related information and introductions to suppliers and partners in Austria.